Caporaso J. G. Kuczynski J. Stombaugh J. Bittinger K. Bushman F. D. Costello E. K. et al.

Verhofstad N. Pennings J. L. A. van Oostrom C. T. van Benthem J. van Schooten F. J. van Steeg H. et al.

Although digestive and extra digestive pathologies have been linked to compositional or functional alterations of the gut microbiota BaP-induced perturbations of the human gut microbiota have not been previously studied.The BaP dosages chosen for this work were informed by two previous studies carried out on the interaction between theBaP and the gut microbiota allowing us to make comparisons and discussions    .

CD received a graduate grant from the Ministere de l'Enseignement Superieur et de la Recherche of France.SUPPLEMENTARY MATERIALThe Supplementary Material for this article can be found online at REFERENCESAbubucker S. Segata N. Goll J. Schubert A. M. Izard J. Cantarel B. L. et al.

Ba Q. Li J. Huang C. Qiu H. Li J. Chu R. et al.

Bouhlel J. Ratel J. Abouelkaram S. Mercier F. Travel A. Baeza E. et al.

Lee J. Kim S. Moon J. Kim S. Kang D. and Yoon H. 2016.

Ueng T. Chang Y. Tsai Y. Su J. Chan P. Shih J. et al.

White A. J. Bradshaw P. T. Herring A. H. Teitelbaum S. L. Beyea J. Stellman S. D. et al.

81562. doi Abbreviations AhR aryl hydrocarbon receptor BaP benzoapyrene ECSIM environmental control system for intestinal microbiota FM fecal microbiota GIT gastrointestinal tract IARC International Agency for Research on Cancer IBD inflammatory bowel disease PAH polycyclic aromatic hydrocarbon PCoA principal coordinate analysis TCDF 2378- tetrachloro dibenzofuran VOC volatile organic compound.

